Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vivo

Description of key information

EDG-Na2 was considered non-mutagenic in the Salmonella typhimurium reverse mutation assay with and without metabolic activation system and negative in the HGPRT. EDG-Na2 when administered orally at 1555.2 mg /kg bw was non-mutagenic in the in vivo micronucleus test in mouse bone marrow cells.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Additional information

Additional information from genetic toxicity in vivo:

Results derived from the genotoxicity tests with EDG-Na2 and the structurally related substance NTA-Na3 (see also read across document in section 13) are sufficient to cover the data requirement for in vitro and in vivo mutagenicity under REACH. NTA itself does not appear to exert genotoxic effects. In certain target tissues (e.g. kidney) high NTA concentrations may form Zn-NTA, for which an aneuploidigenic effect may not be excluded. However, NTA as such is considered non-mutagenic.

Justification for selection of genetic toxicity endpoint

Well performed in vivo test

Justification for classification or non-classification

Because of all the data available on genotoxicity it is concluded that EDG-Na2 does not need classification for genetic toxicity.